However, because COVID-19 disease outcome was compared to controls, it is unknown whether the increased AT1R and ETAR autoantibodies are specifically related to COVID-19 pathogenesis or the result of severe respiratory illness in general. This evidence concerns the gene AGTR1 and COVID-19.